Effect of Dose Modifications on 5-Year Efficacy of Dasatinib and Imatinib in Newly Diagnosed Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) From DASISION
作者
Jörge E. Cortes,Andreas Hochhaus,Hagop M. Kantarjian,François Guilhot,Vamsi K Kota,Timothy P. Hughes,Suresh G. Shelat,Oumar Sy,Elias Joseph Jabbour